Academic Journal
A combination of all-trans retinoic acid derivative and COX-2 inhibitor has anticancer effects in human pharyngeal carcinoma cells
Title: | A combination of all-trans retinoic acid derivative and COX-2 inhibitor has anticancer effects in human pharyngeal carcinoma cells |
---|---|
Authors: | Le Zhu, Lei Xiong, Jianshang Huang, Chonggui Jiang, Wentao Xu, Jing Zhang, Chaojie Hu, Ying Zhong, Zijian Dong, Feihu Chen, Huaqing Zhu, Wei-Ting Kuo, Feng Cao, Li Zuo |
Source: | Heliyon, Vol 9, Iss 11, Pp e21664- (2023) |
Publisher Information: | Elsevier, 2023. |
Publication Year: | 2023 |
Collection: | LCC:Science (General) LCC:Social sciences (General) |
Subject Terms: | Pharyngeal cancer, Celecoxib, ATPR, Cox-2, Extrinsic and intrinsic apoptosis, Proliferation, Science (General), Q1-390, Social sciences (General), H1-99 |
More Details: | Backgrounds and aims: Carcinogenesis is characterized by an unlimited growth of cells exacerbated by Cox-2 overexpression. Cox-2 inhibitors have been proven effective in preventing and treating tumors. In our previous studies, we found that 4-Amino-2-Trifluoromethylphenyl Retinate (ATPR) induces cell apoptosis and inhibits cell proliferation to exhibit anti-cancer properties. The use of ATRA as well as Cox-2 inhibitors in clinical settings can cause adverse reactions. It is unknown what the effects and mechanisms of co-administration of ATPR and Cox-2 inhibitors are. Results: A combination of ATPR and Cox-2 inhibitors, Celecoxib, inhibited pharyngeal cancer cell proliferation in vitro and induced apoptosis. The cell cycle was arrested at G0/G1 by activating P53 and CDNA1. By activating MAPK/JNK pathways, ATPR and Celecoxib led to intrinsic and extrinsic apoptosis in pharyngeal cancer cells. ATPR/Celecoxib combined treatment suppressed tumor growth in the pharyngeal cancer cell-derived xenograft mouse model by increasing the number of apoptotic cells. The expression of the RARA and PTGS2 genes was significantly increased in tumor tissue compared to non-tumor tissue in the clinical analysis of the head and neck squamous cell carcinoma dataset. An association was found between this and the level of intrinsic apoptotic signals. Furthermore, a survival analysis conducted over a period of five years indicated that higher levels of RARA expression were associated with a better clinical outcome. Conclusion: ATPR and celecoxib inhibit the proliferation of cancer cells as well as induce apoptosis. Co-administration of ATPR and Cox-2 inhibitors has the potential to be a novel treatment plan for cancer. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 2405-8440 |
Relation: | http://www.sciencedirect.com/science/article/pii/S2405844023088722; https://doaj.org/toc/2405-8440 |
DOI: | 10.1016/j.heliyon.2023.e21664 |
Access URL: | https://doaj.org/article/c92c51cf35bc4cb4ab088de9ab7c787b |
Accession Number: | edsdoj.92c51cf35bc4cb4ab088de9ab7c787b |
Database: | Directory of Open Access Journals |
ISSN: | 24058440 |
---|---|
DOI: | 10.1016/j.heliyon.2023.e21664 |
Published in: | Heliyon |
Language: | English |